You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 167 No. 2, January 22, 2007 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  Original Investigation
 •Online Features
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (37)
 •Contact me when this article is cited
 Related Content
 •Related letters
 •Similar articles in this journal
 Topic Collections
 •Aging/ Geriatrics
 •Public Health
 •Substance Abuse/ Alcoholism
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Injection Drug Users in the United States, 1979-2002

An Aging Population

Gregory L. Armstrong, MD

Arch Intern Med. 2007;167(2):166-173.

Background  Injection drug use (IDU) is important in the epidemiology of blood-borne pathogens. Herein, trends in IDU from 1979 to 2002 are analyzed.

Methods  The National Household Survey on Drug Abuse is an ongoing survey of drug use among the US population 12 years and older. Participants were chosen using a multistage sampling design and interviewed by written questionnaire (1979-1998) or audio computer-assisted self-interviewing (1999-2002). Herein, we examine the prevalence of a history of IDU at any time in the past (IDU-ever) or within the past year.

Results  In the 2000-2002 surveys, 1.5% (95% confidence interval [CI], 1.4%-1.6%) reported IDU-ever (weighted estimate, 3.4 million persons). Prevalence was highest in persons aged 35 to 49 years (3.1%; 95% CI, 2.8%-3.4%), was higher in men (2.0%; 95% CI, 1.8%-2.2%) than women (1.0%; 95% CI, 0.9%-1.1%), and was higher in whites (1.7%; 95% CI, 1.5%-1.8%) than blacks (0.8%; 95% CI, 0.7%-1.1%) or Hispanics (1.1%; 95% CI, 0.8%-1.4%). Prevalence decreased with increasing annual income and educational level. Of all participants, 0.19% (95% CI, 0.16%-0.23%) reported IDU within the past year (weighted estimate, 440 000 persons). Ten years earlier (1990-1992), 1.6% (95% CI, 1.5%-1.8%) reported IDU-ever; prevalence did not differ by race. From 1979 through 2002, the mean age of participants with IDU within the past year increased from 21 to 36 years; the age of participants with IDU-ever increased from 26 to 42 years. From 2000 to 2002, 59.4% of all persons with IDU-ever were aged 35 to 49 years.

Conclusions  The mean age of injection drug users has increased substantially. Persons born between the late 1940s and early 1960s have the highest prevalence of IDU-ever. Self-reported IDU rates are now lower among young blacks than young whites.


Author Affiliation: Division of Viral Hepatitis, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Ga.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED LETTERS

Chronic Venous Disease and Injection Drug Use
Barbara Pieper, Robert S. Kirsner, Thomas N. Templin, and Thomas J. Birk
Arch Intern Med. 2007;167(16):1807.
EXTRACT | FULL TEXT  

Prisoners (Should) Count
Robert G. Newman
Arch Intern Med. 2007;167(16):1807.
EXTRACT | FULL TEXT  

Prisoners (Should) Count—Reply
Gregory L. Armstrong
Arch Intern Med. 2007;167(16):1807-1808.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

HIV Infection, Immune Suppression, and Uncontrolled Viremia Are Associated With Increased Multimorbidity Among Aging Injection Drug Users
Salter et al.
Clinical Infectious Diseases 2011;53:1256-1264.
ABSTRACT | FULL TEXT  

Priorities for Screening and Treatment of Latent Tuberculosis Infection in the United States
Linas et al.
Am. J. Respir. Crit. Care Med. 2011;184:590-601.
ABSTRACT | FULL TEXT  

Turning 18 with congenital heart disease: prediction of infective endocarditis based on a large population
Verheugt et al.
Eur Heart J 2011;32:1926-1934.
ABSTRACT | FULL TEXT  

Drug-Intake Methods and Social Identity: The Use of Marijuana in Blunts Among Southeast Asian Adolescents and Emerging Adults
Soller and Lee
Journal of Adolescent Research 2010;25:783-806.
ABSTRACT  

Hepatitis C Virus Prevalence and Clearance among US Blood Donors, 2006-2007: Associations with Birth Cohort, Multiple Pregnancies, and Body Mass Index
Murphy et al.
The Journal of Infectious Disease 2010;202:576-584.
ABSTRACT | FULL TEXT  

Gender and Outcome in Adult Congenital Heart Disease
Verheugt et al.
Circulation 2008;118:26-32.
ABSTRACT | FULL TEXT  

Prevalence of Hepatitis C Virus Infection among Injection Drug Users in the United States, 1994-2004
Amon et al.
Clinical Infectious Diseases 2008;46:1852-1858.
ABSTRACT | FULL TEXT  

Injection Drug Use: An Understudied Cause of Venous Disease
Pieper et al.
Arch Dermatol 2007;143:1305-1309.
ABSTRACT | FULL TEXT  

Chronic Venous Disease and Injection Drug Use
Pieper et al.
Arch Intern Med 2007;167:1807-1807.
FULL TEXT  

Prisoners (Should) Count
Newman
Arch Intern Med 2007;167:1807-1807.
FULL TEXT  

Prisoners (Should) Count Reply
Armstrong
Arch Intern Med 2007;167:1807-1808.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2007 American Medical Association. All Rights Reserved.